Antimicrobial resistance: a microbial risk assessment perspective.

The emergence of antimicrobial-resistant microorganisms in both humans and food animals is a growing concern. Debate has centred on links between antimicrobial use in the production of food animals and the emergence of resistant organisms in the human population. Consequently, microbial risk assessment (MRA) is being used to facilitate scientific investigations of the risks related to the food chain, including quantification of uncertainty and prioritization of control strategies. MRA is a scientific tool that can be used to evaluate the level of exposure and the subsequent risk to human health relating to a specific organism or particular type of resistance. This paper reviews the recent applications of MRA in the area of antimicrobial resistance, and in particular, it focuses on the methods, assumptions and data limitations. Since MRA outputs are dependent on the quality of data inputs used in their development, we aim to promote the generation of good quality data by describing the properties that data should ideally possess for MRA and by highlighting the benefit of data generation specifically for inclusion in MRAs.

[1]  Douglas A Popken,et al.  Quantifying Human Health Risks from Virginiamycin Used in Chickens , 2004, Risk analysis : an official publication of the Society for Risk Analysis.

[2]  F. Aarestrup,et al.  Associations between the use of antimicrobial agents for growth promotion and the occurrence of resistance among Enterococcus faecium from broilers and pigs in Denmark, Finland, and Norway. , 2000, Microbial drug resistance.

[3]  P. Fey,et al.  Characterization of Plasmids Carrying CMY-2 from Expanded-Spectrum Cephalosporin-Resistant Salmonella Strains Isolated in the United States between 1996 and 1998 , 2002, Antimicrobial Agents and Chemotherapy.

[4]  N. Bolder,et al.  The induction of quinolone resistance in Campylobacter bacteria in broilers by quinolone treatment , 1994 .

[5]  M. Zervos,et al.  Occurrence and epidemiology of resistance to virginiamycin and streptogramins. , 1999, The Journal of antimicrobial chemotherapy.

[6]  A M Lammerding,et al.  Hazard identification and exposure assessment for microbial food safety risk assessment. , 2000, International journal of food microbiology.

[7]  J. Rose,et al.  Quantitative Microbial Risk Assessment , 1999 .

[8]  R. Leclercq.  Enterococci acquire new kinds of resistance. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  M. Casewell,et al.  An assessment of the impact of antibiotic resistance in different bacterial species and of the contribution of animal sources to resistance in human infections. , 2000, The Journal of antimicrobial chemotherapy.

[10]  B. Murray.  New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. , 1991, The Journal of infectious diseases.

[11]  L. Kelly,et al.  Estimating the risk of importation of foot-and-mouth disease into Europe , 2002, Veterinary Record.

[12]  S. A. Anderson,et al.  Risk assessment of the impact on human health of resistant Campylobacter jejuni from fluoroquinolone use in beef cattle , 2001 .

[13]  A. Vatopoulos,et al.  Indications of in vivo transfer of an epidemic R plasmid from Salmonella enteritidis to Escherichia coli of the normal human gut flora , 1996, Journal of clinical microbiology.

[14]  F. Aarestrup,et al.  Glycopeptide resistance in Enterococcus faecium from broilers and pigs following discontinued use of avoparcin. , 1999, Microbial drug resistance.

[15]  W. Black,et al.  Measurement of Antimicrobial-ResistantEscherichia coli in Pig Feces with a Hydrophobic Grid Membrane Filter Interpreter System , 1998, Applied and Environmental Microbiology.

[16]  J. Prescott,et al.  Antimicrobial therapy in veterinary medicine. , 1988 .

[17]  C. Hart,et al.  Apramycin resistance plasmids in Escherichia coli: possible transfer to Salmonella typhimurium in calves , 1992, Epidemiology and Infection.

[18]  L. Piddock.  Fluoroquinolone resistance , 1998, BMJ.

[19]  B. Love,et al.  Molecular Characterization of Cephalosporin-Resistant Salmonella enterica Serotype Newport Isolates from Animals in Pennsylvania , 2002, Journal of Clinical Microbiology.

[20]  D. Vose.  Risk Analysis: A Quantitative Guide , 2000 .

[21]  M. Woolhouse,et al.  What is antibiotic resistance and how can we measure it? , 2000, Trends in microbiology.

[22]  Johan W Mouton,et al.  European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. , 2003, The Journal of antimicrobial chemotherapy.

[23]  J. Turnidge,et al.  A risk analysis framework for the long-term management of antibiotic resistance in food-producing animals. , 2002, International journal of antimicrobial agents.

[24]  M. Zervos,et al.  Antimicrobial Resistance in Enterococci Isolated from Turkey Flocks Fed Virginiamycin , 1998, Antimicrobial Agents and Chemotherapy.

[25]  G Gettinby,et al.  A quantitative risk assessment for the occurrence of campylobacter in chickens at the point of slaughter , 2001, Epidemiology and Infection.

[26]  David L. Smith,et al.  Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Sheila A. Martin,et al.  Assessing the Risk of Microbial Pathogens: Application of a Judgment-Encoding Methodology. , 1995, Journal of food protection.

[28]  Sarah Cahill,et al.  Risk assessments of Salmonella in eggs and broiler chickens , 2002 .

[29]  N. E. Jensen,et al.  Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[30]  L. Rice.  Emergence of vancomycin-resistant enterococci. , 2001, Emerging infectious diseases.

[31]  W. Witte,et al.  Antibiotics in animal feed. , 2000, Acta veterinaria Scandinavica. Supplementum.

[32]  M. Wierup.  The Swedish experience of the 1986 year ban of antimicrobial growth promoters, with special reference to animal health, disease prevention, productivity, and usage of antimicrobials. , 2001, Microbial drug resistance.

[33]  C Friis,et al.  Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making. , 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[34]  J. D. Mackinnon.  The proper use and benefits of veterinary antimicrobial agents in swine practice. , 1993, Veterinary microbiology.

[35]  M. Gilmore,et al.  Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. , 1998, Emerging infectious diseases.

[36]  R. W. Humphry,et al.  The quantitative measurement of antimicrobial resistance in Escherichia coli at the meta‐population level (meta‐population analysis) , 2002, Letters in applied microbiology.

[37]  G. French.  Enterococci and vancomycin resistance. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  J. L. Smith,et al.  Microbial risk assessment: dose-response relations and risk characterization. , 2000, International journal of food microbiology.

[39]  M H Cassin,et al.  Quantitative risk assessment for Escherichia coli O157:H7 in ground beef hamburgers. , 1998, International journal of food microbiology.

[40]  M. Hinton,et al.  The survival of multi-antibacterial drug-resistant Escherichia coli and Salmonella typhimurium in stored static slurry from a veal calf unit , 1982, Journal of Hygiene.

[41]  L. McDonald,et al.  Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. , 2001, The New England journal of medicine.

[42]  H. Kruse,et al.  Within-sample and between-sample variation of antimicrobial resistance in fecal Escherichia coli isolates from pigs. , 2002, Microbial drug resistance.